Search Results 101-110 of 14178 for anti-TNF drugs

1. COVID-19 (coronavirus) drugs: Are there any that work?

   The corticosteroid dexamethasone is one type of anti-inflammatory drug being studied to treat or prevent organ dysfunction and lung injury from inflammation. A ...

2. Antidepressants: Another weapon against chronic pain - Mayo Clinic

   Medications from other drug classes with distinct mechanisms of pain relief (such as anticonvulsants) may be used in combination with antidepressant class ...

3. The microbiome, fecal microbiota transplants and inflammatory bowel disease - Mayo Clinic

   Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD. MQC-20463208. Medical Professionals; The microbiome, fecal ...

4. Asthma medications: Know your options - Mayo Clinic

   Inhaled corticosteroids. These anti-inflammatory drugs are the most effective and commonly used long-term control medications for asthma. They reduce swelling ...

5. Colorectal cancer prevention: A proven benefit of nonsteroidal anti-inflammatory drugs - Mayo Clinic News Network

   ... anti-inflammatory drugs (NSAIDs), aspirin and several supplements in preventing the recurrence of advanced neoplasia (polyps that are the precursor of ...

6. Prior authorization process can have multiple negative impacts for gastroenterologists and patients with inflammatory bowel disease - Mayo Clinic

   ... agents and small-molecule drugs, early in the course of disease. ... Examining clinical and genetic factors that impact response to anti-TNF agents in patients ...

7. Publications - Konstantinos A. Papadakis, M.D. - Mayo Clinic

   Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists. J Crohns ...

8. Alzheimer's: Medicines help manage symptoms and slow decline - Mayo Clinic

   FDA-approved medicines for treating symptoms · Goals for treating symptoms · Cholinesterase inhibitors · Memantine · Medicine for agitation · Antiamyloid treatment.

9. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

   ... [anti-TNF] agents) within 2 weeks prior to cycle 1, day 1. Patients who have received acute, low dose, systemic immunosuppressant medications (e.g., a one ...

10. How obesity affects IBD management and patient outcomes: Q&A with Amanda M. Johnson, M.D. - Mayo Clinic

    Additionally, some of these drugs are weight-based, while others are fixed doses. ... Examining clinical and genetic factors that impact response to anti-TNF ...